RESEARCH
Neurodegenerative Diseases
The International Journal of Translational Research on the Nervous System
About this Journal
Journal Metrics
Impact Factor: 3.0 | |
CiteScore: 4.3 | |
Acceptance Rate: 29% | |
Time to final decision: 8 weeks | |
Online after acceptance: 13 days |
News & Highlights
Call for Papers
Anti-amyloid Drugs: A Therapeutical Revolution in Alzheimer’s Disease.
Transformative Journal
The Neurodegenerative Diseases Transformative Journal model supports authors and organizations in making a sustainable transition to Open Access, while enabling authors' publishing preferences.
For more information, refer to the journal's guidelines.
New Editor-in-Chief:
Gilles Allali
On the 1st of August 2023, a new cycle initiated for Neurodegenerative Diseases. We welcome Prof. Gilles Allali, head of the Leenaards Memory Centre – CHUV Lausanne, Switzerland, as the new Editor-in-Chief of Neurodegenerative Diseases. Our heartfelt thanks to Prof. Unschuld who led the Journal as Editor-in-Chief for the past 5 and a half years.
Read the Publisher's Note marking this change in leadership: New editorship of Neurodegenerative Diseases
And Prof. Allali’s editorial: A Pivotal Time
Check Out Our Article Collections
Best of Neurodegenerative Diseases
Highly Cited Article Collection of Neurodegenerative Diseases